Product Platforms - Wednesday 14 November 2018

Please note, these sessions are not CPD-accredited.

11:25 - 11:40
Primary Care Training Centre

Physician, train thyself! How do you meet your training needs?

The presentation will look at some of the typical issues and problems faced by Primary Care in making sure that staff are properly trained, and how the PCTC can help to address these issues. Learning outcomes: Recognise the benefit of targeted staff development and training Identify the barriers to effective training Understand the different options…

Rebecca Owen
Diabetes Tutor at Primary Care Training Centre and Diabetes Specialist Nurse
11:45 - 12:00

Online Injection Technique Education, BD and METM

BD’s latest innovation, a patient education programme on injection technique. Complimentary tool to help your insulin treated patients optimally manage self-care. A look at the evidence of injection technique training and BD and Me tool, Easy to use Personalised Evidence based1 Better selfcare2 Better outcomes2 Fewer crises2 References 1. Frid et al. New Insulin Delivery…

12:00 - 12:15
Napp Pharmaceuticals
Napp Diabetes Logo

Canagliflozin: Cardiovascular and Renal outcomes

This session will review Canagliflozin and the cardiovascular and renal outcomes from the CANVAS programme, and discuss the clinical relevance of these findings. How should these results impact our prescribing?

Dr Janaka Karalliedde
Consultant in Diabetes
12:15 - 13:25


14:05 - 14:20

Making self-injecting safer and more comfortable

TickleFLEX is an Insulin Injection Aid for attaching to the end of an insulin pen that makes self-injecting a safer, more comfortable, more consistent and worry-free process. It helps people with diabetes reduce (and often eliminate) pain, anxiety and bruising. TickleFLEX is especially suitable for children and young people, and is now recommended by many…

Peter Bailey
TickleFLEX Inventor
14:20 - 14:35
Roche Logo

Utilising Apps in Diabetes Management

Learn about the latest development in wireless connectivity between BG meters and Apps. Demonstration of the strip-free Accu-Chek® Mobile meter and data transfer to MySugr App

Roche Diabetes Care
14:35 - 15:45


15:45 - 16:00
Dexcom Logo

Dexcom G6 Continuous Glucose Monitoring System

Discover the Dexcom G6, the first real-time diabetes management system approved with Zero fingersticks.

Benjamin Byrne
National Sales Manager, Dexcom
16:05 - 16:20
Medtrum Logo

Medtrum Simplifying Diabetes Care

An introduction to Medtrum® a company dedicated to simplifying diabetes management. We develop and deliver medical devices that aim to meet the needs of people with diabetes, create tools to bring convenience to healthcare professionals, and explore the frontiers in artificial pancreas research. Learning outcomes: Medtrum’s passion, people and products. Medtrum A6 TouchCare System –…

Spencer Martin
UK Business Manager, Medtrum Ltd
Jeevan Kamari
Diabetes Territory Manager, Medtrum Ltd
Jesper Fredman
Training and Education Specialist, Medtrum Ltd
11:20 - 11:40
Urgo Medical
Urgo Medical Logo

Product Demonstration

1. Share the EXPLORER study results and the evidence behind the RCT. 2. Update on the new Best Practice Pathway. 3. Review the impact that URGO Start can have on Neuro-ischaemic DFUs.

Clinical Lead for Podiatry, Solent NHS Trust
12:15 - 13:25


13:25 - 13:40
Flexitol Logo

Product Demonstration

1. Why is callus such a risk factor for ulceration in a patient with diabetes? 2. Understand why urea is so important for the Moderate and high risk patient group with callus as a prevention. 3. Review callus formation. 4. What are the indications for 25% and 10 % urea? When do they need to…

Clinical Lead for Podiatry, Solent NHS Trust
14:05 - 14:20
Thermetrix Logo

A Podium for Diabetic Feet – Empowering Patients in their Personal Care

Diabetic foot ulceration (DFU) is a serious and frequent consequence of diabetes. If detected too late, it can lead to infections, ulcers and eventually amputations. Research literature suggests that up to 80% of DFUs are preventable by daily screening for the early warning signs of increased temperature of the affected area caused by inflammatory reactions…

Dr Peter Plassmann
co-CEO, Thermetrix Ltd
14:20 - 14:35

Prevention of DFU’s GlucoRx, Allpresan – An ideal Moisturiser for your Diabetic Patients

A healthy skin barrier is crucial to protect against mechanical, microbial and chemical damage. If skin is abnormally dry, fissures can develop, the skin loses its elasticity, flexibility and ability to withstand trauma, resulting in skin breakdown and subsequent infection. Dry skin on a diabetic foot is one of the risk factors for foot ulcer…

Tim Dowdall
Healthcare Partnership Manager, DMS, MSc, BSc Hons (Pharmacy)
14:35 - 15:45


15:45 - 16:00
Flexitol Logo

Early detection and costs of diabetic foot complications

How daily foot inspection and the application of urea-based emollients can lead to the early detection of foot complications associated with Diabetes; Comparison of the costs associated with urea-based emollient use vs. diabetes related lower-limb amputation and diabetic foot ulcer management.

Donna Welch
Principal Podiatrist - Diabetes, Humber NHS Foundation Trust
11:25 - 11:40
Glooko Diasend Logo

How to become a diabetes data magician: diasend® tips & tricks

Feeling overwhelmed by the amount of data coming in via your patients? Finding it difficult to harness its full potential to optimise treatment plans? Don’t worry! During this session, you will get an introduction to diasend®, the universal diabetes data management system – offering increased efficiency, better insights and an overall improved clinic/patient collaboration. Matt…

Matthew West
Product Specialist, Glooko
12:00 - 12:15
Innovation Zed
12:15 - 13:25


13:45 - 14:00
Counterweight Logo

Counterweight-Plus: The DiRECT Intervention

Counterweight-Plus is an evidence-based weight management programme for those who require significant weight loss (>15kg) in order to manage high body mass index (BMI) and obesity-associated clinical problems including Type 2 diabetes (T2D). In the DiRECT trial, 46% of people on Counterweight-Plus achieved remission of T2D at 12months, this increased to 73% for those who…

Anna Bell-Higgs
Counterweight Specialist, RD, Counterweight Ltd
14:35 - 15:45


Please note, these sessions are not CPD-accredited.

If you have agreed to receive communications from our sponsors using the DPC2018 registration form and you attend a product platform, you may be contacted by the product platform organisation directly.

Our site is intended for UK Healthcare Professionals

Are you a UK Healthcare Professional?

We’re sending you to our partner charity’s site. 

DRWF provide information and support for people with diabetes and their friends & families